[Detection of the Ki-ras mutation as a specific and sensitive marker of pancreatic carcinoma].
The authors describe the procedure used for assessment of a Ki-ras mutation as a specific and sensitive marker of carcinoma of the pancreas. The reliability of the method was tested in five patients with carcinoma of the pancreas.
Krechler
T
T
1. interní klinika 1. LF UK a VFN, Praha.
Janda
J
J
Dufek
V
V
Kaláb
M
M
Pesková
M
M
Dorazilová
V
V
D000230:Adenocarcinoma / Q000175:diagnosis* / Q000235:genetics; D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000032:analysis; D011905:Genes, ras / Q000235:genetics*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010190:Pancreatic Neoplasms / Q000175:diagnosis* / Q000235:genetics; D017354:Point Mutation; D016133:Polymerase Chain Reaction; D012680:Sensitivity and Specificity
D014408:Biomarkers, Tumor
Průkaz Ki-ras mutace jako specifického a senzitivního markeru karcinomu pankreatu.